![semaglutide cause cancer is Associated with Improved Breast Survival, Lower Metastatic Burden, and a Dose–Survival Relationship Uncoupled from Weight-Loss Magnitude[v1] Glucagon-like peptide-1 medicines and cancer](https://www.preprints.org/frontend/picture/ms_xml/manuscript/b7424c95405790796f3d052b9ff68951/preprints-210091-g002.png)
semaglutide cause cancer is Associated with Improved Breast Survival, Lower Metastatic Burden, and a Dose–Survival Relationship Uncoupled from Weight-Loss Magnitude[v1] Glucagon-like peptide-1 medicines and cancer
USD22.41
USD48.41
Pay in 4 interest-free payments of $5.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
![semaglutide cause cancer is Associated with Improved Breast Survival, Lower Metastatic Burden, and a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] Glucagon-like peptide-1 medicines and cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs43018-025-01110-1/MediaObjects/43018_2025_1110_Fig1_HTML.png)
![semaglutide cause cancer is Associated with Improved Breast Survival, Lower Metastatic Burden, and a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] Glucagon-like peptide-1 medicines and cancer](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3948118049927715081)
![semaglutide cause cancer is Associated with Improved Breast Survival, Lower Metastatic Burden, and a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] Glucagon-like peptide-1 medicines and cancer](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3892297064747178046)
![semaglutide cause cancer is Associated with Improved Breast Survival, Lower Metastatic Burden, and a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] Glucagon-like peptide-1 medicines and cancer](https://i.ytimg.com/vi/QyVz6zrkKrE/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLDrNoCOYSbdYKYC1-CcYtHL8M7YWA)
